The drugmaker said distributors not authorized to sell these medications have sold counterfeits to pharmacies using genuine Gilead bottles that have been tampered with a counterfeit foil induction seal or label and contain bogus pills.
Gilead is working with the FDA to alert affected pharmacies and remove counterfeit and tampered medication from circulation.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
